Cargando…

Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy

Sepsis is a systemic response to infection with a high rate of mortality and complex pathophysiology involving inflammation, infection response, hemostasis, endothelium, and platelets. The purpose of this study was to develop an equation incorporating biomarker levels at intensive care unit (ICU) ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Walborn, Amanda, Rondina, Matthew, Fareed, Jawed, Hoppensteadt, Debra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288806/
https://www.ncbi.nlm.nih.gov/pubmed/32129085
http://dx.doi.org/10.1177/1076029620902849
_version_ 1783545341613703168
author Walborn, Amanda
Rondina, Matthew
Fareed, Jawed
Hoppensteadt, Debra
author_facet Walborn, Amanda
Rondina, Matthew
Fareed, Jawed
Hoppensteadt, Debra
author_sort Walborn, Amanda
collection PubMed
description Sepsis is a systemic response to infection with a high rate of mortality and complex pathophysiology involving inflammation, infection response, hemostasis, endothelium, and platelets. The purpose of this study was to develop an equation incorporating biomarker levels at intensive care unit (ICU) admission to predict mortality in patients with sepsis, based on the hypothesis that a combination of biomarkers representative of multiple physiological systems would provide improved predictive value. Plasma samples and clinical data were collected from 103 adult patients with sepsis at the time of ICU admission. Biomarker levels were measured using commercially available methods. A 28-day mortality was used as the primary end point. Stepwise linear regression modeling was performed to generate a predictive equation for mortality. Differences in biomarker levels between survivors were quantified using the Mann-Whitney test and the area under the receiver operating curve (AUC) was used to describe predictive ability. Significant differences (P < .05) were observed between survivors and nonsurvivors for plasminogen activator inhibitor 1 (AUC = 0.70), procalcitonin (AUC = 0.77), high mobility group box 1 (AUC = 0.67), interleukin (IL) 6 (AUC = 0.70), IL-8 (AUC = 0.70), protein C (AUC = 0.71), angiopoietin-2 (AUC = 0.76), endocan (AUC = 0.58), and platelet factor 4 (AUC = 0.70). A predictive equation for mortality was generated using stepwise linear regression modeling, which incorporated procalcitonin, vascular endothelial growth factor, the IL-6:IL-10 ratio, endocan, and platelet factor 4, and demonstrated a better predictive value for patient outcome than any individual biomarker (AUC = 0.87). The use of mathematical modeling resulted in the development of a predictive equation for sepsis-associated mortality with performance than any individual biomarker or clinical scoring system which incorporated biomarkers representative of multiple systems.
format Online
Article
Text
id pubmed-7288806
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-72888062020-06-22 Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy Walborn, Amanda Rondina, Matthew Fareed, Jawed Hoppensteadt, Debra Clin Appl Thromb Hemost Original Article Sepsis is a systemic response to infection with a high rate of mortality and complex pathophysiology involving inflammation, infection response, hemostasis, endothelium, and platelets. The purpose of this study was to develop an equation incorporating biomarker levels at intensive care unit (ICU) admission to predict mortality in patients with sepsis, based on the hypothesis that a combination of biomarkers representative of multiple physiological systems would provide improved predictive value. Plasma samples and clinical data were collected from 103 adult patients with sepsis at the time of ICU admission. Biomarker levels were measured using commercially available methods. A 28-day mortality was used as the primary end point. Stepwise linear regression modeling was performed to generate a predictive equation for mortality. Differences in biomarker levels between survivors were quantified using the Mann-Whitney test and the area under the receiver operating curve (AUC) was used to describe predictive ability. Significant differences (P < .05) were observed between survivors and nonsurvivors for plasminogen activator inhibitor 1 (AUC = 0.70), procalcitonin (AUC = 0.77), high mobility group box 1 (AUC = 0.67), interleukin (IL) 6 (AUC = 0.70), IL-8 (AUC = 0.70), protein C (AUC = 0.71), angiopoietin-2 (AUC = 0.76), endocan (AUC = 0.58), and platelet factor 4 (AUC = 0.70). A predictive equation for mortality was generated using stepwise linear regression modeling, which incorporated procalcitonin, vascular endothelial growth factor, the IL-6:IL-10 ratio, endocan, and platelet factor 4, and demonstrated a better predictive value for patient outcome than any individual biomarker (AUC = 0.87). The use of mathematical modeling resulted in the development of a predictive equation for sepsis-associated mortality with performance than any individual biomarker or clinical scoring system which incorporated biomarkers representative of multiple systems. SAGE Publications 2020-03-04 /pmc/articles/PMC7288806/ /pubmed/32129085 http://dx.doi.org/10.1177/1076029620902849 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Walborn, Amanda
Rondina, Matthew
Fareed, Jawed
Hoppensteadt, Debra
Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy
title Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy
title_full Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy
title_fullStr Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy
title_full_unstemmed Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy
title_short Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy
title_sort development of an algorithm to predict mortality in patients with sepsis and coagulopathy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288806/
https://www.ncbi.nlm.nih.gov/pubmed/32129085
http://dx.doi.org/10.1177/1076029620902849
work_keys_str_mv AT walbornamanda developmentofanalgorithmtopredictmortalityinpatientswithsepsisandcoagulopathy
AT rondinamatthew developmentofanalgorithmtopredictmortalityinpatientswithsepsisandcoagulopathy
AT fareedjawed developmentofanalgorithmtopredictmortalityinpatientswithsepsisandcoagulopathy
AT hoppensteadtdebra developmentofanalgorithmtopredictmortalityinpatientswithsepsisandcoagulopathy